SecProbe.io

<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.txt
<TEXT>
                        Bio Solutions International, Inc.
                               1281 SW 28th Avenue
                             Boynton Beach, FL 33426
                                 (561) 436 7064

July 5, 2005

U.S. Securities and Exchange Commission
Division of Corporate Finance
Attn: Rufus Decker, Branch Chief
Mail Stop 0510
Washington, DC 20549-0510

RE:  Biosolutions International, Inc.
     Form 10-KSB for the fiscal year ended June 30, 2004
     Forms 10-QSB for the quarters ended September 30, 2004
     and December 31, 2004
     File No.: 33-25126-D

Dear Mr. Decker:

This is in response to your letter dated June 7, 2005.

1.  Pursuant  to your  request,  I hereby and the  Company  acknowledge  (1) the
Company is  responsible  for the adequacy and accuracy of the  disclosure in its
entirety;  (2) staff  comments  or changes to  disclosure  in  response to staff
comments do not foreclose the Commission  from taking any action with respect to
the filing;  and (3) the Company may not assert  staff  comments as a defense in
any  proceeding  initiated  by  the  Commission  or  any  person  under  federal
securities laws of the United States.

2. The Company will revise its  disclosures in all future filings to reflect the
proper language.

3. The title "Assets held for sale" on the Balance Sheet was in error. It should
have been "Cash." The  Statement of Cash Flows is correct.  We will make certain
that all future filings are correctly titled.

4. The Company will revise its  disclosures in all future filings to reflect the
proper language.

Sincerely,

/s/ Michael Bobrick
Michael Bobrick, CEO and CFO

</TEXT>
</DOCUMENT>